Literature DB >> 20846815

Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection.

Yu Chen1, Zhenjing Chen, Renyong Guo, Nan Chen, Haifeng Lu, Shuai Huang, Jie Wang, Lanjuan Li.   

Abstract

This study aims to compare the diversity of intestinal fungal microbiota in patients with different degrees of chronic hepatitis B virus (HBV) infection. Culture-independent and culture-dependent methods were performed on 38 patients with hepatitis B cirrhosis, 35 patients with chronic hepatitis B, 33 HBV carriers, and 55 healthy volunteers. An overall fungal biodiversity of 37 different operational taxonomic units was found in the clone libraries; only Candida spp. and Saccharomyces cerevisiae were obtained by the culture-dependent analysis. There was a higher richness of fungal species in patients with hepatitis B cirrhosis than in patients with chronic hepatitis B, and the latter was higher than that in HBV carriers and healthy volunteers. There was little difference in enteric fungal diversity between HBV carriers and healthy volunteers. The results indicate that the diversity of enteric fungi was positively correlated with the disease progression of patients with different degrees of chronic HBV infection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846815     DOI: 10.1016/j.diagmicrobio.2010.04.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  52 in total

1.  Candida albicans culture from a rectal swab can be associated with newly diagnosed colorectal cancer.

Authors:  Lubomír Starý; Kristýna Mezerová; Kamil Vysloužil; Pavel Zbořil; Pavel Skalický; Martin Stašek; Vladislav Raclavský
Journal:  Folia Microbiol (Praha)       Date:  2020-06-29       Impact factor: 2.099

Review 2.  The mycobiome of the human urinary tract: potential roles for fungi in urology.

Authors:  A Lenore Ackerman; David M Underhill
Journal:  Ann Transl Med       Date:  2017-01

Review 3.  Fungi in the healthy human gastrointestinal tract.

Authors:  Heather E Hallen-Adams; Mallory J Suhr
Journal:  Virulence       Date:  2016-10-13       Impact factor: 5.882

Review 4.  The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism.

Authors:  Luigina Romani; Teresa Zelante; Melissa Palmieri; Valerio Napolioni; Matteo Picciolini; Andrea Velardi; Franco Aversa; Paolo Puccetti
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

Review 5.  Mycobiota in gastrointestinal diseases.

Authors:  Pranab K Mukherjee; Boualem Sendid; Gautier Hoarau; Jean-Frédéric Colombel; Daniel Poulain; Mahmoud A Ghannoum
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-11       Impact factor: 46.802

Review 6.  The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.

Authors:  Sunil Thomas; Jacques Izard; Emily Walsh; Kristen Batich; Pakawat Chongsathidkiet; Gerard Clarke; David A Sela; Alexander J Muller; James M Mullin; Korin Albert; John P Gilligan; Katherine DiGuilio; Rima Dilbarova; Walker Alexander; George C Prendergast
Journal:  Cancer Res       Date:  2017-03-14       Impact factor: 12.701

Review 7.  Interplay between viruses and bacterial microbiota in cancer development.

Authors:  Dariia Vyshenska; Khiem C Lam; Natalia Shulzhenko; Andrey Morgun
Journal:  Semin Immunol       Date:  2017-06-09       Impact factor: 11.130

Review 8.  Learning from other diseases: protection and pathology in chronic fungal infections.

Authors:  Teresa Zelante; Giuseppe Pieraccini; Lucia Scaringi; Franco Aversa; Luigina Romani
Journal:  Semin Immunopathol       Date:  2015-09-17       Impact factor: 9.623

9.  Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism?

Authors:  Danielle A Garsin; Michael C Lorenz
Journal:  Gut Microbes       Date:  2013-08-14

10.  Transkingdom Interactions Important for the Pathogenesis of Human Viruses.

Authors:  Andrew Nishimoto; Nicholas Wohlgemuth; Jason Rosch; Stacey Schultz-Cherry; Valerie Cortez; Hannah M Rowe
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.